While co-mutations in KRAS and LKB1 are found in tumors of squamous cell carcinoma and adenocarcinoma, KRAS and TP53 co-mutations are found only in adenocarcinoma [10, 11]. Here, KRAS is linked to squamous cell carcinoma.